(Reuters) -Bristol Myers Squibb and Johnson & Johnson said on Friday they would stop a late-stage trial of their experimental ...

By Deena Beasley (Reuters) -Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...

MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart attack to help ...

Long Beach Medical Center Cardiologists Pioneer Innovative Use of GLP-1 Agonists For decades, GLP-1 agonists—a class of medications including generic names like semaglutide and tirzepatide—have been ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Shares rise 8.5% on enlicitide decanoate Phase 3 data showing LDL reduction. Q3 earnings beat at $2.58/share with $17.3B ...

Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Garlic is also known for causing bad breath and body odour. As allicin breaks down, it releases sulphur containing gases.